Previous 10 | Next 10 |
Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health dietary supplement products, announced financial results for the second quarter and first six months of fiscal year 2024, ended September 30, 2023. Commenting on the second...
Evotec SE (EVO) is expected to report $-0.03 for Q3 2023 Amplifon (AMFPF) is expected to report for Q3 2023 Compass Therapeutics Inc. (CMPX) is expected to report $-0.11 for Q3 2023 Astronics Corp. - Class B (ATROB) is expected to report for Q4 2023 Charge Enterprises Inc. (CRGE) ...
Cyanotech Corporation (CYAN) is expected to report for Q1 2024
2023-08-11 10:35:56 ET Cyanotech press release ( NASDAQ: CYAN ): Q1 GAAP EPS of -$0.22. Revenue of $5.14M (-23.5% Y/Y). For further details see: Cyanotech GAAP EPS of -$0.22, revenue of $5.14M
Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health dietary supplement products, announced financial results for the first quarter of fiscal year 2024, ended June 30, 2023. Commenting on the first quarter fiscal year 2024 re...
Cyanotech Corporation (Nasdaq Capital Market: CYAN), the world innovation leader in the cultivation and manufacture of microalgae for health and nutrition, including BioAstin® Hawaiian Astaxanthin and Hawaiian Spirulina Pacifica® , today announces the appointment of Collette Kak...
2023-06-27 17:13:11 ET Cyanotech press release ( NASDAQ: CYAN ): FY GAAP EPS of -$0.55. Revenue of $23.18M (-35.6% Y/Y). Shares -3.67% AH. For further details see: Cyanotech GAAP EPS of -$0.55, revenue of $23.18M
Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health dietary supplement products, announced financial results for the fourth quarter and fiscal year 2023, ended March 31, 2023. Commenting on the fiscal year results (changes s...
Cyanotech press release ( NASDAQ: CYAN ): Q3 GAAP EPS of -$0.10. Revenue of $5.59M (-40.9% Y/Y). For further details see: Cyanotech GAAP EPS of -$0.10, revenue of $5.59M
Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health dietary supplement products, announced financial results for the third quarter and first nine months of fiscal year 2023, ended December 31, 2022. Commenting on the third q...
News, Short Squeeze, Breakout and More Instantly...
Cyanotech Corporation Company Name:
CYAN Stock Symbol:
NASDAQ Market:
Cyanotech Corporation Website:
Cyanotech Corporation (OTCQB Market: CYAN), a world leader in microalgae-based, high-value nutrition and health dietary supplement products, announced financial results for the fourth quarter and fiscal year 2024, ended March 31, 2024. Commenting on the fiscal year results (changes shown vs...
GreenTree Hospitality Group Ltd. American depositary shares each representing one Class A (GHG) is expected to report for Q1 2024 Air T Inc. (AIRT) is expected to report for Q4 2024 Alimentation-Couche Tard Inc. - Class A (Multiple Voting) (ANCTF) is expected to report for Q4 2024 Man...
The new gummy offers an industry-leading 12mg of Hawaiian Astaxanthin ® per serving – 6000 times the antioxidant power of Vitamin C – with science-backed, multifunctional benefits and a 40-year legacy of farm-direct transparency and traceability. Nutrex-Hawaii...